SCHEMBL7160485

SCHEMBL7160485

O=C1NCCn2c(-c3cccc(CN4CCCC4)c3)cc3cccc1c32

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7164770 0.91 PARP1 (0.77) PARP1
SCHEMBL7165693 0.83 PARP1 (1.00) PARP1
SCHEMBL7162218 0.83 PARP1 (1.00) PARP1
SCHEMBL6204233 0.82 PARP1 (1.00) PARP1
SCHEMBL5074040 0.82 PARP1 (0.76) PARP1
SCHEMBL6201404 0.77 PARP1 (0.76) PARP1
SCHEMBL6202464 0.77 PARP1 (1.00) PARP1
SCHEMBL6198880 0.77 PARP1 (1.00) PARP1
SCHEMBL7163103 0.76 PARP1 (1.00) PARP1
SCHEMBL7159231 0.76 PARP1 (1.00) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 US disclosed